Angela K. Berger

488 total citations
9 papers, 337 citations indexed

About

Angela K. Berger is a scholar working on Infectious Diseases, Molecular Biology and Genetics. According to data from OpenAlex, Angela K. Berger has authored 9 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Angela K. Berger's work include Viral gastroenteritis research and epidemiology (7 papers), Virus-based gene therapy research (4 papers) and Cell death mechanisms and regulation (3 papers). Angela K. Berger is often cited by papers focused on Viral gastroenteritis research and epidemiology (7 papers), Virus-based gene therapy research (4 papers) and Cell death mechanisms and regulation (3 papers). Angela K. Berger collaborates with scholars based in United States. Angela K. Berger's co-authors include Pranav Danthi, Bernardo A. Mainou, Joseph A. Gredell, S. Patrick Walton, Daniel B. Kearns, Hong Yi, Sandra S. Zinkel, Andrea J. Pruijssers, Terence S. Dermody and Geoffrey H. Holm and has published in prestigious journals such as Journal of Virology, PLoS Pathogens and Virology.

In The Last Decade

Angela K. Berger

9 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela K. Berger United States 8 190 167 114 53 50 9 337
Iva I. Podgorski Croatia 10 156 0.8× 152 0.9× 260 2.3× 76 1.4× 33 0.7× 21 401
Lijo John India 11 114 0.6× 200 1.2× 89 0.8× 18 0.3× 59 1.2× 22 395
Stephen B. Deitz United States 11 136 0.7× 178 1.1× 41 0.4× 23 0.4× 54 1.1× 12 415
Margarito Rojas Mexico 7 203 1.1× 205 1.2× 75 0.7× 99 1.9× 60 1.2× 8 453
Kankan Yang China 12 130 0.7× 138 0.8× 115 1.0× 136 2.6× 22 0.4× 29 328
E. Breyel Germany 6 55 0.3× 197 1.2× 46 0.4× 33 0.6× 67 1.3× 12 399
R S Wonderling United States 10 84 0.4× 223 1.3× 315 2.8× 58 1.1× 44 0.9× 11 384
Laura S. Ooms United States 7 266 1.4× 81 0.5× 180 1.6× 93 1.8× 26 0.5× 9 334
Moushumee Das India 6 78 0.4× 87 0.5× 96 0.8× 146 2.8× 30 0.6× 9 349
Jianlin Fu Singapore 8 279 1.5× 122 0.7× 23 0.2× 73 1.4× 42 0.8× 8 466

Countries citing papers authored by Angela K. Berger

Since Specialization
Citations

This map shows the geographic impact of Angela K. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela K. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela K. Berger more than expected).

Fields of papers citing papers by Angela K. Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela K. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela K. Berger. The network helps show where Angela K. Berger may publish in the future.

Co-authorship network of co-authors of Angela K. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Angela K. Berger. A scholar is included among the top collaborators of Angela K. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela K. Berger. Angela K. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Berger, Angela K., et al.. (2019). Enhanced Killing of Triple-Negative Breast Cancer Cells by Reassortant Reovirus and Topoisomerase Inhibitors. Journal of Virology. 93(23). 20 indexed citations
2.
Berger, Angela K. & Bernardo A. Mainou. (2018). Interactions between Enteric Bacteria and Eukaryotic Viruses Impact the Outcome of Infection. Viruses. 10(1). 19–19. 35 indexed citations
3.
Berger, Angela K., Hong Yi, Daniel B. Kearns, & Bernardo A. Mainou. (2017). Bacteria and bacterial envelope components enhance mammalian reovirus thermostability. PLoS Pathogens. 13(12). e1006768–e1006768. 71 indexed citations
4.
Berger, Angela K., et al.. (2017). Viral RNA at Two Stages of Reovirus Infection Is Required for the Induction of Necroptosis. Journal of Virology. 91(6). 37 indexed citations
5.
Berger, Angela K., et al.. (2015). Viral gene expression potentiates reovirus-induced necrosis. Virology. 484. 386–394. 14 indexed citations
6.
Berger, Angela K. & Pranav Danthi. (2013). Reovirus Activates a Caspase-Independent Cell Death Pathway. mBio. 4(3). e00178–13. 68 indexed citations
7.
Danthi, Pranav, Andrea J. Pruijssers, Angela K. Berger, et al.. (2010). Bid Regulates the Pathogenesis of Neurotropic Reovirus. PLoS Pathogens. 6(7). e1000980–e1000980. 35 indexed citations
8.
Gredell, Joseph A., Angela K. Berger, & S. Patrick Walton. (2008). Impact of target mRNA structure on siRNA silencing efficiency: A large‐scale study. Biotechnology and Bioengineering. 100(4). 744–755. 56 indexed citations
9.
Berger, Angela K.. (1998). Vaccine delivery system using safe bacteria invented. BMJ. 317(7159). 620.3–620.3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026